BioXcel Therapeutics, Inc.

BioXcel Therapeutics (BTAI): A New Haven-Based Clinical-Stage Neuroscience Company Navigating IGALMI Commercialization and Pipeline Restructuring Under Liquidity Pressure

In-depth research on BTAI covering the business overview, key financial moves, risk frame, and the bottom-line on what changed since the last report.